Interestingly, PAK2 was found to be more active in castration-resistant prostate cancers compared to castration-sensitive cancers and to contribute to prostate cancer cell invasion as well as proliferation in vitro [48]. This evidence concerns the gene PAK2 and prostate carcinoma.